Inhibition of Phosphoglycerate Dehydrogenase Radiosensitizes Human Colorectal Cancer Cells under Hypoxic Conditions
(2022) Cancers — Vol. 14, n° 20, p. 5060 [1-17] (2022)
Files
InhibitionofPhosphoglycerateDehydrogenaseRadiosensitizes.pdf
Open Access - Adobe PDF
- 2.32 MB
Details
- Authors
Van de Gucht, Melissa 
Kerkhove, Lisa De Ridder, Mark
- Abstract
- Augmented de novo serine synthesis activity is increasingly apparent in distinct types of cancers and has mainly sparked interest by investigation of phosphoglycerate dehydrogenase (PHGDH). Overexpression of PHGDH has been associated with higher tumor grade, shorter relapse time and decreased overall survival. It is well known that therapeutic outcomes in cancer patients can be improved by reprogramming metabolic pathways in combination with standard treatment options, for example, radiotherapy. In this study, possible metabolic changes related to radioresponse were explored upon PHGDH inhibition. Additionally, we evaluated whether PHGDH inhibition could improve radioresponse in human colorectal cancer cell lines in both aerobic and radiobiological relevant hypoxic conditions. Dysregulation of reactive oxygen species (ROS) homeostasis and dysfunction in mitochondrial energy metabolism and oxygen consumption rate were indicative of potential radiomodulatory effects. We demonstrated that PHGDH inhibition radiosensitized hypoxic human colorectal cancer cells while leaving intrinsic radiosensitivity unaffected. In a xenograft model, the first hints of additive effects between PHGDH inhibition and radiotherapy were demonstrated. In conclusion, this study is the first to show that modulation of de novo serine biosynthesis enhances radioresponse in hypoxic colorectal cancer cells, mainly mediated by increased levels of intracellular ROS.
- Affiliations
Citations
Van de Gucht, M., Dufait, I., Kerkhove, L., Corbet, C., de Mey, S., Jiang, H., Law, K. L., Gevaert, T., Feron, O., & De Ridder, M. (2022). Inhibition of Phosphoglycerate Dehydrogenase Radiosensitizes Human Colorectal Cancer Cells under Hypoxic Conditions. Cancers, 14(20), 5060 [1-17]. https://doi.org/10.3390/cancers14205060 (Original work published 2022)